Delivery Order SPE2DR25D1034-SPE2DR26FPX1E
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $8,324.76 to AmerisourceBergen Drug Corp for the supply of Rifampin 300 mg capsules (60-count units) on September 15, 2025, with completion targeted for September 16, 2025. This firm fixed-price, competitively awarded contract carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 13, 2026, for the supply of Rifampin 300 mg capsules in quantities of 60 units, with a ceiling value of $6,960.94 and an ultimate completion date of January 14, 2026. This non-set-aside, competitively awarded contract reflects a firm fixed-price delivery order structure and represents a task order under the company's broader pharmaceutical supply agreement with DLA Troop Support Medical. The place...
- The Defense Logistics Agency awarded a delivery order valued at $3,928.15 to AmerisourceBergen Drug Corp for the supply of Rifampin 300 mg capsules (60-count units) on January 13, 2026, with an ultimate completion date of January 14, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Rifampin 150 mg capsules (30-count units) with a contract ceiling value of $1,909.54. This firm fixed-price, competitively awarded delivery order is scheduled for completion by June 17, 2025, with performance at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The contract contains no set-aside designation and represents one...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Rifampin 300 mg capsules (60-count units) with a ceiling value of $31,201.41. This is a firm fixed price delivery order with no set-aside designation, representing a competitively awarded contract under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The ultimate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Rifampin 150 mg capsules (30-count units) on December 17, 2025, with a ceiling value of $1,061.60 and ultimate completion date of December 18, 2025. This is a firm fixed-price, non-set-aside contract with performance at the contractor's Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a $6.82K delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Rifampin 300 mg capsules (60-count). The contract, which carries a firm fixed price and requires completion by December 3, 2025, represents a non-set-aside competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and is performing the work at its corporate office...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on July 30, 2025, for the supply of Rifampin 300 mg capsules (60-count). This firm fixed-price contract, valued at $2,602.40, represents a non-competitive award and is scheduled for completion by July 31, 2025. The pharmaceutical product will be performed and delivered from the contractor's Conshohocken facility. This delivery order is issued under...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Rifampin Capsules under a firm fixed-price contract valued at $28,815.84, with completion scheduled for July 29, 2025. This is a non-set-aside, competitively awarded delivery order executed as a child contract. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., received a delivery order valued at $1,442.42 from the Defense Logistics Agency for Rifampin 300 mg capsules (60-count). The order was awarded on January 9, 2026, on a firm fixed-price basis with an ultimate completion date of January 12, 2026. The contract carries no set-aside designation, indicating it was competitively awarded. The place of performance is located at the awardee's corporate office in Conshohocken, Pennsylvania. This...
- SPE2DR25D1034Indefinite Delivery Contract
- SPE2DR25D1034-SPE2DR26FPX1EDelivery Order
On January 14, 2026, the Defense Logistics Agency (DLA) awarded a delivery order valued at $1,125.35 to AmerisourceBergen Drug Corp for the supply of Rifampin 300 mg capsule unit dose packages (100 count). This firm fixed-price, competitively awarded contract (no set-aside designation) is scheduled for completion by January 15, 2026, with performance taking place at the awardee's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., operates as a critical pharmaceutical distributor supporting federal medical procurement needs for military and veteran healthcare systems. This delivery order is executed under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. This comprehensive IDC vehicle enables the company to supply a broad range of pharmaceutical products and medical supplies globally to support military healthcare programs and other federal medical institutions. The contract reflects AmerisourceBergen's established capability to efficiently fulfill federal procurement requirements for essential medications and medical commodities across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 1/13/26 |